KC
Therapeutic Areas
Ossium Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HPC, Marrow | Hematopoietic Stem Cell Transplantation (e.g., blood cancers) | Phase 1/2 |
| CD34+ Product | Organ Transplant Rejection (Immune Tolerance) | Phase 1 |
| OssiGraft | Orthopedic Bone Healing (e.g., Spinal Fusion) | Early Commercial/Clinical |